publication venue for
- Molecular diagnostics in follicular non-Hodgkin's lymphoma: A review 2000
- Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module. 1997
- A PHASE-II STUDY OF IFOSFAMIDE, CISPLATIN, ETOPOSIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A PRELIMINARY-REPORT 1990
- Colorectal Cancer in Young Adults. 36:439-450. 2009
- Introduction—Impact of Malignant Diseases on Young Adults II. 36:380-380. 2009
- The Adolescence of Young Adult Oncology. 36:478-488. 2009
- Cancer in Young Adults 20 to 39 Years of Age: Overview. 36:194-206. 2009
- Psychosocial Issues and Quality of Life. 36:275-280. 2009
- Cowden Syndrome. 34:428-434. 2007
- Pemetrexed safety and dosing strategy. 29:24-29. 2002
- Pemetrexed safety and dosing strategy. 29:24-29. 2002
- Zoledronic acid in the treatment of hypercalcemia of malignancy: Results of the international clinical development program. 28:17-24. 2001
- Molecular diagnostics in follicular non-Hodgkin's lymphoma: a review.. 27:42-52. 2000
- Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.. 24:S8-27-S8-30. 1997
- Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: An estimate using the population health model lung cancer module. 24:S56-S63. 1997
- An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer. 23:82-89. 1996
- An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer.. 23:82-89. 1996
- A PHASE-II STUDY OF IFOSFAMIDE IN COMBINATION WITH ETOPOSIDE AND CISPLATIN IN THE TREATMENT OF EXTENSIVE SMALL-CELL LUNG-CANCER. 19:51-57. 1992
- A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.. 19:51-56. 1992
- Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.. 19:54-58. 1992
- A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.. 17:19-23. 1990
- The diagnosis and treatment of thrombosis in the cancer patient.. 17:160-171. 1990
- COMBINATION CHEMOTHERAPY CONFERS MODEST SURVIVAL ADVANTAGE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CANCER - REPORT OF A CANADIAN MULTICENTER RANDOMIZED TRIAL. 15:42-45. 1988
- Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trial.. 15:42-45. 1988
- MEGESTROL-ACETATE PLUS MINIDOSE DIETHYLSTILBESTROL IN THE TREATMENT OF CARCINOMA OF THE PROSTATE. 15:62-67. 1988
- Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.. 15:62-67. 1988
- 1ST-LINE THERAPY WITH VP-16 AND CISPLATIN FOR SMALL-CELL LUNG-CANCER. 13:17-23. 1986
- Combined chemotherapy and radiation therapy for non-small-cell lung cancer.. 13:121-124. 1986
- First-line therapy with VP-16 and cisplatin for small-cell lung cancer.. 13:17-23. 1986
- THE USE OF VP-16 PLUS CISPLATIN DURING INDUCTION CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER. 13:10-16. 1986
- The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.. 13:10-16. 1986
- PERUGIA INTERNATIONAL CANCER CONFERENCE .1. DISCUSSION 1988